Koninklijke Philips N.V. (RYLPF)
USD 24.33
(9.46%)
USD 24.33
(9.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.95 Billion EUR | -4.28% |
| 2022 | 7.27 Billion EUR | 12.31% |
| 2021 | 6.47 Billion EUR | 13.46% |
| 2020 | 5.7 Billion EUR | 15.51% |
| 2019 | 4.93 Billion EUR | 44.12% |
| 2018 | 3.42 Billion EUR | -15.26% |
| 2017 | 4.04 Billion EUR | 0.57% |
| 2016 | 4.02 Billion EUR | -1.81% |
| 2015 | 4.09 Billion EUR | 10.32% |
| 2014 | 3.71 Billion EUR | 12.18% |
| 2013 | 3.3 Billion EUR | -11.17% |
| 2012 | 3.72 Billion EUR | 13.64% |
| 2011 | 3.27 Billion EUR | 16.32% |
| 2010 | 2.81 Billion EUR | -22.58% |
| 2009 | 3.64 Billion EUR | 5.02% |
| 2008 | 3.46 Billion EUR | 185.5% |
| 2007 | 1.21 Billion EUR | -59.61% |
| 2006 | 3 Billion EUR | -9.39% |
| 2005 | 3.31 Billion EUR | -6.55% |
| 2004 | 3.54 Billion EUR | -15.17% |
| 2003 | 4.18 Billion EUR | -35.61% |
| 2002 | 6.49 Billion EUR | -1.64% |
| 2001 | 6.6 Billion EUR | 188.45% |
| 2000 | 2.29 Billion EUR | -16.56% |
| 1999 | 2.74 Billion EUR | -0.92% |
| 1998 | 2.77 Billion EUR | -15.7% |
| 1997 | 3.28 Billion EUR | -8.5% |
| 1996 | 3.59 Billion EUR | 12.75% |
| 1995 | 3.18 Billion EUR | -44.34% |
| 1994 | 5.72 Billion EUR | -6.06% |
| 1993 | 6.09 Billion EUR | -12.59% |
| 1992 | 6.96 Billion EUR | 41.0% |
| 1991 | 4.94 Billion EUR | -3.94% |
| 1990 | 5.14 Billion EUR | 16.1% |
| 1989 | 4.43 Billion EUR | 2.88% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 7.13 Billion EUR | 0.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q4 | 6.95 Billion EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q2 | 7.17 Billion EUR | 0.0% |
| 2023 FY | 6.95 Billion EUR | -4.28% |
| 2023 Q3 | - EUR | -100.0% |
| 2022 Q2 | 6.78 Billion EUR | 0.0% |
| 2022 FY | 7.27 Billion EUR | 12.31% |
| 2022 Q4 | 7.27 Billion EUR | 0.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 FY | 6.47 Billion EUR | 13.46% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 5.88 Billion EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 6.47 Billion EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 6.7 Billion EUR | 0.0% |
| 2020 Q4 | 5.7 Billion EUR | 0.0% |
| 2020 FY | 5.7 Billion EUR | 15.51% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 FY | 4.93 Billion EUR | 44.12% |
| 2019 Q4 | 4.93 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 4.78 Billion EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2018 Q4 | 3.42 Billion EUR | 0.0% |
| 2018 FY | 3.42 Billion EUR | -15.26% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q2 | 3.68 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2017 Q1 | 3.96 Billion EUR | -1.29% |
| 2017 FY | 4.04 Billion EUR | 0.57% |
| 2017 Q4 | 4.04 Billion EUR | -8.94% |
| 2017 Q3 | 4.44 Billion EUR | 70.87% |
| 2017 Q2 | 2.59 Billion EUR | -34.52% |
| 2016 Q1 | 3.98 Billion EUR | -2.71% |
| 2016 Q4 | 4.02 Billion EUR | -17.26% |
| 2016 Q3 | 4.86 Billion EUR | -7.76% |
| 2016 Q2 | 5.26 Billion EUR | 32.25% |
| 2016 FY | 4.02 Billion EUR | -1.81% |
| 2015 Q3 | 3.97 Billion EUR | -1.85% |
| 2015 FY | 4.09 Billion EUR | 10.32% |
| 2015 Q1 | 4.11 Billion EUR | 10.94% |
| 2015 Q4 | 4.09 Billion EUR | 3.07% |
| 2015 Q2 | 4.04 Billion EUR | -1.7% |
| 2014 Q2 | 3.33 Billion EUR | 0.76% |
| 2014 Q1 | 3.31 Billion EUR | 0.06% |
| 2014 Q4 | 3.71 Billion EUR | 3.57% |
| 2014 Q3 | 3.58 Billion EUR | 7.43% |
| 2014 FY | 3.71 Billion EUR | 12.18% |
| 2013 Q2 | 3.5 Billion EUR | -1.66% |
| 2013 Q4 | 3.3 Billion EUR | -1.93% |
| 2013 FY | 3.3 Billion EUR | -11.17% |
| 2013 Q1 | 3.56 Billion EUR | -4.43% |
| 2013 Q3 | 3.37 Billion EUR | -3.63% |
| 2012 Q4 | 3.72 Billion EUR | -2.92% |
| 2012 FY | 3.72 Billion EUR | 13.64% |
| 2012 Q1 | 3.97 Billion EUR | 21.26% |
| 2012 Q2 | 4.12 Billion EUR | 3.72% |
| 2012 Q3 | 3.83 Billion EUR | -6.94% |
| 2011 FY | 3.27 Billion EUR | 16.32% |
| 2011 Q1 | 2.67 Billion EUR | -5.07% |
| 2011 Q2 | 2.7 Billion EUR | 1.05% |
| 2011 Q3 | 2.93 Billion EUR | 8.4% |
| 2011 Q4 | 3.27 Billion EUR | 11.88% |
| 2010 Q3 | 2.77 Billion EUR | -9.01% |
| 2010 Q4 | 2.81 Billion EUR | 1.44% |
| 2010 Q1 | 3.54 Billion EUR | -2.66% |
| 2010 FY | 2.81 Billion EUR | -22.58% |
| 2010 Q2 | 3.05 Billion EUR | -13.83% |
| 2009 Q3 | 3.59 Billion EUR | -3.93% |
| 2009 FY | 3.64 Billion EUR | 5.02% |
| 2009 Q2 | 3.74 Billion EUR | -2.09% |
| 2009 Q1 | 3.82 Billion EUR | 11.16% |
| 2009 Q4 | 3.64 Billion EUR | 1.17% |
| 2008 Q2 | 3.15 Billion EUR | -0.45% |
| 2008 Q3 | 3.29 Billion EUR | 4.42% |
| 2008 FY | 3.46 Billion EUR | 185.5% |
| 2008 Q4 | 3.44 Billion EUR | 4.44% |
| 2008 Q1 | 3.16 Billion EUR | 161.05% |
| 2007 Q2 | 1.33 Billion EUR | -54.45% |
| 2007 Q1 | 2.92 Billion EUR | -2.65% |
| 2007 FY | 1.21 Billion EUR | -59.61% |
| 2007 Q4 | 1.21 Billion EUR | -67.72% |
| 2007 Q3 | 3.76 Billion EUR | 182.15% |
| 2006 Q4 | 3 Billion EUR | -1.0% |
| 2006 FY | 3 Billion EUR | -9.39% |
| 2006 Q3 | 3.03 Billion EUR | -4.8% |
| 2006 Q2 | 3.18 Billion EUR | -1.52% |
| 2006 Q1 | 3.23 Billion EUR | -2.39% |
| 2005 Q4 | 3.31 Billion EUR | -1.65% |
| 2005 Q1 | 3.6 Billion EUR | 1.6% |
| 2005 Q2 | 3.64 Billion EUR | 1.02% |
| 2005 FY | 3.31 Billion EUR | -6.55% |
| 2005 Q3 | 3.37 Billion EUR | -7.42% |
| 2004 Q1 | 4.31 Billion EUR | 3.09% |
| 2004 FY | 3.54 Billion EUR | -15.17% |
| 2004 Q4 | 3.54 Billion EUR | -7.54% |
| 2004 Q3 | 3.83 Billion EUR | -8.72% |
| 2004 Q2 | 4.2 Billion EUR | -2.51% |
| 2003 Q1 | 6.33 Billion EUR | -2.49% |
| 2003 FY | 4.18 Billion EUR | -35.61% |
| 2003 Q4 | 4.18 Billion EUR | -5.12% |
| 2003 Q3 | 4.41 Billion EUR | -14.77% |
| 2003 Q2 | 5.17 Billion EUR | -18.33% |
| 2002 Q3 | 11.24 Billion EUR | 44.32% |
| 2002 Q4 | 6.49 Billion EUR | -42.23% |
| 2002 Q1 | 7.98 Billion EUR | 20.94% |
| 2002 FY | 6.49 Billion EUR | -1.64% |
| 2002 Q2 | 7.79 Billion EUR | -2.45% |
| 2001 Q4 | 6.6 Billion EUR | -19.98% |
| 2001 Q1 | 5.39 Billion EUR | 135.66% |
| 2001 Q3 | 8.25 Billion EUR | 32.82% |
| 2001 FY | 6.6 Billion EUR | 188.45% |
| 2001 Q2 | 6.21 Billion EUR | 15.17% |
| 2000 Q4 | 2.29 Billion EUR | -34.75% |
| 2000 Q3 | 3.5 Billion EUR | 2.18% |
| 2000 FY | 2.29 Billion EUR | -16.56% |
| 2000 Q1 | 3.28 Billion EUR | 19.81% |
| 2000 Q2 | 3.43 Billion EUR | 4.45% |
| 1999 Q4 | 2.74 Billion EUR | -18.52% |
| 1999 FY | 2.74 Billion EUR | -0.92% |
| 1999 Q1 | 3.46 Billion EUR | 24.91% |
| 1999 Q2 | 3.48 Billion EUR | 0.6% |
| 1999 Q3 | 3.36 Billion EUR | -3.22% |
| 1998 Q1 | 3.18 Billion EUR | -3.06% |
| 1998 Q2 | 2.96 Billion EUR | -6.77% |
| 1998 Q4 | 2.77 Billion EUR | -2.54% |
| 1998 Q3 | 2.84 Billion EUR | -4.29% |
| 1998 FY | 2.77 Billion EUR | -15.7% |
| 1997 Q3 | 5.55 Billion EUR | -9.9% |
| 1997 Q4 | 3.28 Billion EUR | -40.86% |
| 1997 FY | 3.28 Billion EUR | -8.5% |
| 1997 Q1 | 5.9 Billion EUR | 64.44% |
| 1997 Q2 | 6.16 Billion EUR | 4.43% |
| 1996 FY | 3.59 Billion EUR | 12.75% |
| 1996 Q4 | 3.59 Billion EUR | 0.0% |
| 1995 FY | 3.18 Billion EUR | -44.34% |
| 1995 Q4 | 3.18 Billion EUR | 0.0% |
| 1994 FY | 5.72 Billion EUR | -6.06% |
| 1994 Q4 | 5.72 Billion EUR | 0.0% |
| 1993 Q4 | 6.09 Billion EUR | 0.0% |
| 1993 FY | 6.09 Billion EUR | -12.59% |
| 1992 FY | 6.96 Billion EUR | 41.0% |
| 1992 Q4 | 6.96 Billion EUR | 0.0% |
| 1991 FY | 4.94 Billion EUR | -3.94% |
| 1991 Q4 | 4.94 Billion EUR | 0.0% |
| 1990 FY | 5.14 Billion EUR | 16.1% |
| 1990 Q4 | 5.14 Billion EUR | 0.0% |
| 1989 FY | 4.43 Billion EUR | 2.88% |
| 1989 Q4 | 4.43 Billion EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -2158385.369% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Aurora Spine Corporation | 1.59 Million USD | -437074.467% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1548123.181% |
| Avitar, Inc. | 3.89 Million USD | -178498.376% |
| BioElectronics Corporation | 12.52 Million USD | -55440.343% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Broncus Holding Corporation | 1.22 Million USD | -568445.752% |
| Brain Scientific Inc. | 7378.00 USD | -94320854.188% |
| BrainsWay Ltd. | 239 Thousand USD | -2911615.481% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| Health Logic Interactive Inc. | - USD | -Infinity% |
| CVR Medical Corp. | - USD | -Infinity% |
| NIOX Group Plc | 500 Thousand USD | -1391700.0% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | -1179391.525% |
| ECGI Holdings, Inc. | 804 Thousand USD | -865447.264% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | -1125951.78% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -4639233.333% |
| Escalon Medical Corp. | 279.4 Thousand USD | -2490558.688% |
| Lombard Medical, Inc. | 28.02 Million USD | -24731.401% |
| Fuse Medical, Inc. | 200 Thousand USD | -3479400.0% |
| Guided Therapeutics, Inc. | 511 Thousand USD | -1361739.53% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | -41556.062% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | -1307304.429% |
| IR-Med Inc. | 161 Thousand USD | -4322260.248% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -3197808.194% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | -754.691% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -5996246.528% |
| Nanomix Corporation | 10.11 Million USD | -68722.893% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 2.78 Million USD | -249655.144% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | -2131.865% |
| Össur hf. | 311.8 Million USD | -2131.865% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -4299188.291% |
| Polarean Imaging plc | 74.84 Thousand USD | -9297658.063% |
| Positron Corporation | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -4889276.023% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Vivos Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -15933135.644% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -1617388.117% |
| Smith & Nephew plc | 2.17 Billion USD | -220.406% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -1414330.894% |
| SS Innovations International, Inc. | 1.91 Million USD | -364163.161% |
| Stratec SE | 89.25 Million USD | -7696.699% |
| Theraclion SA | 1.95 Million EUR | -356637.149% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Urologix, Inc. | 4.58 Million USD | -151644.44% |
| QHSLab, Inc. | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| VMS Rehab Systems, Inc. | 106.45 USD | -6537341374.871% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -2860307.667% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -2284535.588% |
| Wellstar International, Inc. | 18.86 Million USD | -36795.112% |
| Zecotek Photonics Inc. | - USD | -Infinity% |